26 results about "Tumor associated antigen" patented technology

Tumor-specific antigens ( TSAs) typically result from a tumor specific mutation and are targetted for non-self attack when displayed on class I histocompatibility molecules. Tumor-associated antigens ( TAAs) are more common than TSAs, and are presented both by tumor cells and by normal cells.